The African Surgical Outcomes Study (ASOS) showed that surgical patients in Africa have a mortality twice the global average. The working hypothesis is that patients die as a result of failure to rescue following complications in the postoperative period. The African Surgical OutcomeS-2 (ASOS-2) Trial plans to test the efficacy of increased postoperative surveillance in high risk patients for decreasing perioperative morbidity and mortality. This pilot trial aimed i) to evaluate the adequacy of data produced by the data collection strategies of the ASOS-2 Trial, ii) to evaluate the fidelity of implementation of the increased postoperative surveillance intervention, and iii) to understand the acceptability, appropriateness and feasibility of the intervention and the trial processes.
Introduction
The African Surgical Outcomes Study (ASOS) 1 was designed to provide robust surgical outcomes data from Africa, to inform the Commission on Global Surgery. 2 ASOS showed that surgical patients in Africa were generally young, and of a low surgical risk, yet, when compared to the global average, they were twice as likely to die following surgery. 1 It is possible that the increase in mortality was predominantly secondary to failure to rescue, which is death following complications. 1 ASOS suggested that limited surgical resources, in terms of personnel and facilities, compromise provision of a safe postoperative environment for surgical patients in Africa.
The limited variation in postoperative morbidity and mortality across the countries in ASOS, 1 suggests that a continent-wide strategy to provide safer postoperative care may decrease surgical mortality in Africa. With limited resources available for postoperative care, a strategy is needed that focuses care on the patients at greatest risk of severe complications and death. Identifying high-risk patients and instituting increased postoperative surveillance selectively for these patients may decrease failure to rescue, and hence decrease mortality. This is the strategy which has been adopted for the African Surgical OutcomeS-2 (ASOS-2) Trial; a cluster randomised trial to determine whether increased postoperative surveillance of adult African surgical patients reduces postoperative mortality. 3 The objectives of the ASOS-2 Pilot Trial were: i) to evaluate the adequacy of data produced by the sampling and data collection strategies of the ASOS-2 Trial, ii) to evaluate the fidelity of implementation of the trial intervention, and iii) to understand the acceptability, appropriateness and feasibility of the intervention and the trial processes.
Methods
This pilot study is presented in accordance with the CONSORT recommendations for randomised pilot and feasibility trials. 4 
Trial design
The proposed ASOS-2 Trial is a pragmatic trial. It is an international cluster randomised controlled trial in African countries. Participating surgical sites will be randomised to either the intervention arm of increased postoperative surveillance or the control arm of usual postoperative care. All consecutive adult patients aged 18 years and over admitted to participating sites undergoing elective and non-elective surgery are to be included in the trial. Sites which have been randomised to the intervention arm will need to provide increased postoperative surveillance to those surgical patients with a risk score of ≥ 10 according to the ASOS Surgical Risk Calculator. The ASOS Surgical Risk Calculator was developed from the first ASOS data and recently published elsewhere. 5 The primary outcome of the ASOS-2 Trial is inhospital mortality, censored at 30 days.
The ASOS-2 Pilot Trial was a mixed-methods (quantitativequalitative) implementation study evaluating the intervention arm of the proposed ASOS-2 Trial. For the pilot trial the intervention protocol was implemented at all sites for a sevenday period at which time data collection was stopped. Data was collected by means of a case report form (CRF) and an electronic post-pilot survey (Appendices 1 and 2). The CRF documented the necessary data to measure: i) completeness of trial data and ii) fidelity of implementation of the intervention. The survey was used to collect additional data on the implementation outcomes (fidelity, acceptability, appropriateness and feasibility). The survey contained two sections: i) the study intervention (increased postoperative surveillance guided by the risk calculator), and ii) the trial processes. The types of questions used were a combination of Likert scale and open questions. The ASOS-2 Pilot Trial was not registered on a trial registry.
Participants
Eligible participants included all consecutive adult patients aged 18 years and over admitted to participating sites undergoing elective and non-elective surgery. Pilot sites were selected based on readiness to participate. Only sites with full local ethical approval could participate in the pilot. The initial ethics approval was from the Human Research and Ethics Committee of the University of Cape Town (HREC 081/2018). The trial has a waiver of individual consent, and operated on a broadcast consent model, where participating sites broadcast their involvement in the trial by means of publicly visible posters.
The post-pilot survey was conducted on the REDCap platform 6 and distributed via email to named investigators one week after the pilot project. Survey responses were anonymous.
Interventions
All eligible surgical patients were screened with the ASOS Surgical Risk Calculator. 5 Patients scoring 10 or more points, were considered high-risk, as they have a predicted incidence of severe complications and death above the average for the ASOS cohort. 5 The protocol required that these patients receive increased postoperative surveillance which included the following components: i) admission to a higher care ward than had been planned prior to risk stratification, ii) an increase in the frequency of postoperative nursing observations, iii) ensuring that the patient is placed in view of the nursing station, and not in a remote location in the ward, or iv) allowing family members to stay with the patient in the ward. The care givers were encouraged to provide as many of the components of the intervention, for as long as possible to the high-risk patients. A bedside clinical guidance poster was provided for all high-risk patients with information on the leading causes of postoperative mortality in African surgical patients as documented in ASOS; these were surgical site infections, bloodstream infection and acute respiratory distress syndrome, pneumonia, acute kidney injury, postoperative bleeding, and cardiac arrest. 1 A WhatsApp messaging programme was integrated into the REDCap data collection tool. The WhatsApp programme provided automated responsive data collection reminders to support clinician registration and to improve data integrity and completeness.
Outcomes
The effectiveness outcomes (mortality and severe complications) of the ASOS-2 Trial were not captured during the ASOS-2 Pilot Trial, as data collection was stopped at seven days and the pilot was not powered to measure these outcomes. Based on our previous ASOS experience, we are confident that we can capture these data during the full trial. 1 The implementation outcomes of the pilot were: i) percentage completeness of data produced by the sampling and data collection strategies, ii) fidelity of implementation of the trial intervention, and iii) acceptability, appropriateness and feasibility of the intervention and the trial processes.
Fidelity was defined as individual patient level exposure to increased surveillance, measured quantitatively with the CRF. It assessed the number of surveillance methods a patient was exposed to, the duration of days for which each of these were implemented, and the perceived ease or difficulty of implementation. Acceptability, appropriateness and feasibility were measured qualitatively and semi-quantitatively (by Likert scale) at the individual investigator level by means of a post-pilot investigator survey. Acceptability was defined as stakeholder comfort with the content and complexity of the intervention they are asked to implement. Appropriateness was defined as stakeholder belief about necessity and a goodness of fit of the intervention for their hospital. Feasibility was defined as stakeholder opinion regarding utility and sustainability of the intervention at their hospital. No changes were made to the pilot trial assessments or measurements after the pilot trial commenced.
Theoretical framework
The post-pilot survey was built around the implementation outcomes proposed by Proctor 7 and operationalised using selected questions from the Consolidated Framework for Implementation Research (CFIR) interview guide tool. 8 Essentially the outcome of the ASOS-2 trial depends not only on whether increased postoperative surveillance truly decreases postoperative mortality and morbidity, but also the degree to which increased postoperative surveillance can be implemented in a real-world setting. The CFIR framework addresses elements of the intervention, the context and the process as drivers of fidelity of implementation. Although the questions in the postpilot survey were modelled around an established framework, they have not been validated in this setting, and for this reason the survey employed a mixed-methods approach.
The pilot trial was conducted to inform changes to the proposed protocol to ensure the success of the ASOS-2 Trial, as such there were no prespecified criteria used to judge whether to proceed with a future definitive trial.
Sample size
There was no proposed sample size for the pilot trial. The sample represents the maximum number of trial centres that were willing to participate and had full ethical approval at the date determined for the pilot trial. There were no stopping rules for the pilot trial, as the trial was to run for one week, and there would be insufficient time to determine any indication for stopping. The survey sampling strategy aimed to avoid duplicate responses by sending a link to the electronic survey to individual named investigators.
All pilot sites were in the intervention arm, hence there was no randomisation, or need for allocation concealment. There was no blinding in the pilot trial.
Implementation
All patients who had surgery from Monday to Friday of the recruitment week, were risk stratified using the ASOS Surgical Risk Calculator at the time of surgery by the anaesthetist. 5 Any patient with a score of 10 or more, was considered high-risk, and 
Statistical analysis
Quantitative analyses. When appropriate, categorical variables were compared using Fisher's exact test. Likert scale responses were treated as ordinal data and summarised using proportions (n/N [%]). Continuous variables were tested and confirmed for normality, summarised using mean and standard deviation, and compared using unpaired t-tests, as all data was normally distributed. 
Recruitment
Each pilot site selected a single recruitment week between September and November 2018.
Patient characteristics
The patients' characteristics are shown in Table 1 The ease and difficulty of providing the individual components of increased postoperative surveillance are shown in Table 3 . The components of increased postoperative surveillance most frequently unavailable were the ability to provide care in a higher care ward (32%) and assigning the patient to a bed in view of the nurses' station (28%). When provided, the easiest components to implement were assigning the patient to a bed in view of the nurses' station (39%) or having the family with the patient in the ward (39%). A failure to comply with the available components of the intervention (not done) ranged from 28% to 54%.
The post ASOS-2 Pilot Trial survey
The post-pilot survey had a response rate of 30/40 (75%). Of the respondents, 15 were anaesthesia providers, 14 were surgery providers, and one was a nurse. Likert responses to questions about acceptability, appropriateness, fidelity, and feasibility of the intervention is shown in Table 4 , the trial processes in Table  5 , and qualitative responses in Supplementary Table 1 .
In response to Likert scale questions about acceptability of the various components of the intervention, 63% to 84% of respondents rated the components acceptable, except for family presence at the bedside, which only 37% of respondents rated as acceptable. In response to Likert questions about stakeholder involvement and leadership, 64% to 76% of respondents indicated agreement with the trial processes. The qualitative responses suggested that the full range of stakeholders, from family and frontline staff, to heads of departments (HODs) and hospital management need engagement in the implementation process.
The respondents generally agreed that the CRF was acceptable.
Respondents were less decisive about the REDCap data capturing system, 5/11 (45%) agreed it was 'straightforward' , while 4/11 (36%) remained undecided.
80% of the respondents believe that they have the capacity to do ASOS network projects annually.
The qualitative questions were structured to elicit information on specific aspects of implementation, however, many of the responses overlapped between the questions. The central themes that were identified in the responses are presented in the coding matrix (Supplemental Table 1 ). These themes can be summarised as a need for improved communication with stakeholders, development of site investigator teams, managing the concern of limited resource capacity, and streamlining the trial process.
No adverse events related to the trial were reported.
Discussion

Statement of principal findings
The ASOS-2 Pilot Trial had three objectives. With respect to the first objective, the pilot trial suggested that the data produced by the sampling and data collection strategies was good with almost 98% complete data collection for the pilot. The data was sufficiently pragmatic to describe the cohort, allow risk stratification, and characterise the intervention adequately. The cohort description supports data adequacy since the patients and the procedures correspond with those recorded in the first ASOS study.
The second objective was to evaluate the fidelity of implementation of the trial intervention. The pilot trial suggests that the ASOS Surgical Risk Calculator 5 is easy to use to identify the high-risk patient. The individual components of the intervention were implemented in less than 50% of high-risk patients (with the exception of increasing nursing observations) ( Table 2 ). The compliance with the intervention may therefore be considered poor, especially as the individual components could have been increased by between 28% and 54% in the current cohort, and most respondents considered the components of the intervention 'easy' to implement with the exception of placement in a higher care ward (Table 3 ). An important observation is that despite our assessment of the compliance with the intervention being poor, the respondents believed that they had indeed provided 'increased postoperative surveillance' to the 'high-risk' patients ( Table 4 ).
The third objective was to understand the acceptability, appropriateness and feasibility of the intervention. The pilot suggests that the proposed ASOS-2 Trial is acceptable, appropriate and feasible. The majority of the qualitative responses were very supportive of the proposed intervention (Supplementary Table  1 ). The only component of the intervention which the median respondent considered unacceptable was having the patient's family at the bedside. The qualitative responses suggested that this was multifactorial; which included staffing attitudes, hospital policy, security, and ward space. The trial intervention was generally considered acceptable. Involving stakeholders was considered simple by the investigators. However, the hospital which provided data on only 75% of all eligible patients screened, had particular difficulty establishing a pilot trial hospital team. The qualitative data clearly identifies that the stakeholders in the trial cover the broad range of hospital management, surgeons, anaesthetists, nursing staff, and other frontline ward staff.
The trial processes suggest that the negative score for Caesarean section on the ASOS Surgical Risk Calculator, creates the impression that obstetrics is not considered as a serious risk factor. Occasional disagreement between clinical impression of a patient and the ASOS Surgical Risk Calculator was mentioned. The WhatsApp messaging was found to be useful, although there was no consensus on the appropriate number of messages, or the composition of the WhatsApp hospital site investigator group. Some concerns were raised about the data capturing process, specifically the need to return to the data base multiple times for data capture on the same patient.
Limitations
The pilot trial has poor representation from district hospitals. Furthermore, the pilot did not assess the main trial outcomes, although we are confident in the ability of the investigators to capture these data, as they are similar to those successfully collected across Africa in ASOS. 1 It is possible that the duration of the components of the intervention may be under-reported, as the pilot trial stopped on the Monday, which is only the third postoperative day for 'high-risk' patients recruited on the Friday into the trial. Acceptable definitions for data completeness and fidelity were not prespecified. This shortcoming will be addressed in the main trial. The pilot survey respondents are not representative of all the key individuals identified in the survey. The anonymous nature of the survey means that we did not collect data regarding the respondents' country or hospital. Therefore, we cannot distinguish differences in responses at a country or hospital level.
Generalisability
The pilot trial methods and findings may be generalisable to the definitive trial due to: i) completeness of the data collection, and ii) the consistency in the survey responses regarding acceptability, appropriateness, and feasibility in the survey, despite data from hospitals across eight African countries. Importantly, there was overwhelming support for the appropriateness of the proposed intervention in the qualitative assessment. The page number in the footer is not for bibliographic referencing www.tandfonline.com 23
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Interpretation
We believe that the pilot trial was successful, as it has provided valuable information on all three of its objectives. These data have important implications for progression from the pilot to the future definitive trial.
To improve fidelity we must secure: i) a representative local trial team with accepted leadership structure at each hospital, ii) buyin to a shared vision by all key individuals, iii) define adequacy of increased surveillance, iv) improve education and training on implementation of the intervention, and v) identify agreed workarounds for barriers to implementation that are specific to the sites (e.g. address problems with ward layout, bed allocation and family visitation policies). These goals can be achieved by involving a broader range of stakeholders in the local trial team, increasing contact time with site investigators during the buildup to the trial, increasing education during site enrolment and initiation, and providing a roll-in period for the site to test the protocol and establish acceptable workarounds prior to the ASOS-2 Trial.
Although the ASOS Surgical Risk Calculator was simple to use for risk stratification in the pilot trial, it is necessary to educate investigators in the principles related to i) the derivation of the calculator (and hence the individual point scores), ii) the expected outcomes associated with a score above the cut for high-risk in the trial, immaterial of the clinical impression, and iii) the expected number of patients that will require increased surveillance per day.
The WhatsApp groups may need to be individualised according to local needs at each site. Moreover, it would be desirable to simplify the patient data capture portal. We believe this will be possible in the definitive trial, when the questions around 'fidelity' of implementation which were specific to the pilot trial will be removed.
Exposure to the individual components of the proposed intervention was suboptimal. A key focus of education during site initiation will be on ensuring that each component of the intervention is maximally applied during the trial. A concern that needs to be addressed, is the current perception that increased postoperative surveillance was done, even though there was substantial room for improvement in delivering the intervention. The recurring concern about resource constraints is a reality of the setting; it should be clarified that the goal of the intervention is not to increase workload for frontline staff, but rather to redistribute resources to those at higher risk of complication.
Conclusion
Morbidity and mortality following surgery in Africa is significantly worse than the global average. These poor outcomes appear to be consistent across many African countries, a phenomenon which is possibly driven by 'failure to rescue' . 1 The proposed 'increased postoperative surveillance' intervention for the ASOS-2 Trial appears to be appropriate, acceptable and feasible in Africa. This pilot trial provides substantial support for the proposed trial. It emphasises the need to establish site teams that address the needs of all stakeholders, the need to help stakeholders identify ways to work around site specific barriers to implementation, and finally, the need to pursue increased compliance with all the components of the proposed intervention of 'increased postoperative surveillance' .
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Appendix 1. ASOS-2 Pilot Trial case record form (CRF)
The page number in the footer is not for bibliographic referencing www.tandfonline.com 27 The infection appears to be related to the surgical procedure and involves deep soft tissues of the incision (e.g. fascial and muscle layers) and iii) The patient has at least one of the following: a) purulent drainage from the deep incision but not from the organ/space component of the surgical site, or b) a deep incision spontaneously dehisces or is deliberately opened by a surgeon and is culture-positive or no cultures were taken whilst the patient has at least one of the following signs or symptoms of infection: fever (>38°C) or localized pain or tenderness. A culture-negative finding does not meet this criterion, or c) an abscess or other evidence of infection involving the deep incision is found on direct examination, during surgery, or by histopathologic or radiologic examination, or d) diagnosis of a deep incisional surgical site infection by a surgeon or attending physician. Surgical site infection (organ/space): An infection which involves any part of the body excluding the fascia or muscle layers and meets the following criteria: i) Infection occurs within 30 days after surgery and ii) The infection appears to be related to the surgical procedure and involves any part of the body, excluding the skin incision, fascia, or muscle layers, that is opened or manipulated during the operative procedure and iii) The patient has at least one of the following: a) purulent drainage from a drain that is placed through a stab wound into the organ/space, b) organisms isolated from an aseptically obtained culture of fluid or tissue in the organ/ space , or c) an abscess or other, or d) evidence of infection involving the organ/space that is found on direct examination, during reoperation, or by histopathologic or radiologic examination, or e) diagnosis of an organ/space surgical site infection by a surgeon or attending physician.
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Bloodstream infection:
An infection which is not related to infection at another site and which meets at least one of the following criteria: i) Patient has a recognised pathogen cultured from blood cultures which is not related to an infection at another site, ii) Patient has at least one of the following signs or symptoms: fever (>38°C), chills, or hypotension and at least one of the following: a) common skin contaminant cultured from two or more blood cultures drawn on separate occasions, or b) common skin contaminant cultured from at least one blood culture from a patient with an intravascular line, and a physician starts antimicrobial therapy, or c) positive blood antigen test. Acute Respiratory Distress Syndrome (ARDS): Respiratory failure, or new or worsening respiratory symptoms, commencing within one week of surgery; and a chest radiograph or computed tomography scan which demonstrates bilateral opacities not fully explained by effusions, lobar/lung collapse, or nodules; and respiratory failure not fully explained by cardiac failure or fluid overload. Need objective assessment (e.g. echocardiography) to exclude hydrostatic oedema if no risk factor is present. Severity grading: Severe: PaO2:FiO2 ≤100 mmHg with PEEP ≥5 cmH2O. Guidance: If altitude is higher than 1000 m, a correction factor should be calculated as follows: (PaO2:FiO2 x [barometric pressure/760 mmHg]). PEEP, positive end-expiratory pressure; CPAP, non-invasive continuous positive airways pressure. Pneumonia: Chest radiographs with new or progressive and persistent infiltrates, or consolidation, or cavitation, and at least one of the following: i) fever (>38°C) with no other recognized cause, or ii) leucopaenia (<4,000 white blood cells/mm3) or leucocytosis (>12,000 white blood cells/mm3), or iii) for adults >70 years old, altered mental status with no other recognised cause; and at least two of the following: a) new onset of purulent sputum or change in character of sputum, or increased respiratory secretions, or increased suctioning requirements, or b) new onset or worsening cough, or dyspnoea, or tachypnoea, or c) rales or bronchial breath sounds, d) worsening gas exchange (hypoxaemia, increased oxygen requirement or increased ventilator demand). Guidance: Two radiographs are required for patients with underlying pulmonary or cardiac disease. The definition may be used to identify ventilator associated pneumonia. Urinary tract infection: An infection associated with at least one of the following signs or symptoms which should be identified within a 24 hour period; fever (>38 °C), urgency, frequency, dysuria, suprapubic tenderness, costovertebral angle pain or tenderness with no other recognised cause, and a positive urine culture of ≥105 colony forming units/mL with no more than two species of microorganisms. Acute Kidney Injury (AKI): Serum creatinine Increase of 3.0 times baseline within 7 days or increase in serum creatinine to ≥4.0 mg/dL (≥354 μmol/L) with an acute rise of >0.5 mg/dL (>44 μmol/L) or initiation of renal replacement therapy, or urine output ≤0.3 ml/kg/h for 24 hours or anuria for 12 hours Guidance: Baseline serum creatinine must be measured before surgery but an estimated value can be used if the patient does not have chronic kidney disease. Postoperative haemorrhage: Blood loss occurring within 72 hours after the end of surgery which would normally result in transfusion of blood. Cardiac arrest: The cessation of cardiac mechanical activity, as confirmed by the absence of signs of circulation. ECG changes may corroborate the incidence of cardiac arrest. Other severe complications: If any of the following complications result in a significant prolongation of hospital stay and/or permanent functional limitation or death, then mark 'Other severe complication' as 'Yes'. Note that they will almost always requires clinical treatment. Critical care admission to treat postoperative complications: Postoperative complications requiring admission to critical care to treat the postoperative complications or provide critical care support necessitated by the severity of the postoperative complications. Days in hospital after surgery: Total number of days in hospital after surgery. Status at hospital discharge or 30th postoperative in-hospital day: The survival status of the patient at hospital discharge, or at the 30 in-hospital day (if the patient had not yet been discharged following surgery). The study is censored at the 30th in hospital postoperative day. 
